Antigen kinetics determines immune reactivity

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0706296105PMID 18362362PMCID PMC2278203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold spring harb symp quant biol. 1989. 54: 1-13.

  2013cited by this paper
• Structural and kinetic basis for heightened immunogenicity of T cell vaccines

  2005cited by this paper
• Toll‐like receptor ligands as adjuvants in allergen‐specific immunotherapy

  2005cited by this paper
• Immunity in response to particulate antigen-delivery systems.

  2005cited by this paper
• Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design1

  2005cited by this paper
• An innately interesting decade of research in immunology

  2004cited by this paper
• Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides.

  2004cited by this paper
• CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells

  2004cited by this paper
• Tolerance, not immunity, crucially depends on IL-2

  2004cited by this paper
• Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes

  2003cited by this paper
• Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

  2003cited by this paper
• Oligodeoxynucleotide Studies in Primates: Antisense and Immune Stimulatory Indications

  2003cited by this paper
• Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

  2003cited by this paper
• Recent advances in the discovery and delivery of vaccine adjuvants

  2003cited by this paper
• Continuous T cell receptor signaling required for synapse maintenance and full effector potential

  2003cited by this paper
• Role of Toll‐like receptors in costimulating cytotoxic T cell responses

  2003cited by this paper
• Essential Role for IL-2 in the Regulation of Antiviral Extralymphoid CD8 T Cell Responses1

  2002cited by this paper
• A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding.

  2002cited by this paper
• Vaccines: Effector and memory T-cell differentiation: implications for vaccine development

  2002cited by this paper
• A role for antigen in the maintenance of immunological memory

  2002cited by this paper
• Immunological aspects of controlled antigen delivery.

  2002cited by this paper
• CpG motifs in bacterial DNA and their immune effects.

  2002cited by this paper
• Interleukin-10 and the interleukin-10 receptor.

  2001cited by this paper
• Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation

  2001cited by this paper
• Regulation of the Immune Response by Antigen

  2001cited by this paper
• Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide)

  2000cited by this paper
• Localization dose and time of antigens determine immune reactivity.

  2000cited by this paper
• A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy.

  1999cited by this paper
• Terminal modifications inhibit proteolytic degradation of an immunogenic mart‐127–35 peptide: Implications for peptide vaccines

  1999cited by this paper
• A Structure-based Approach to Designing Non-natural Peptides That Can Activate Anti-melanoma Cytotoxic T Cells*

  1999cited by this paper
• The duration of antigenic stimulation determines the fate of naive and effector T cells.

  1998cited by this paper
• HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice

  1997cited by this paper
• Immunology Taught by Viruses

  1996cited by this paper
• The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

  1996cited by this paper
• Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)- microglobulin-deficient BALB/c mice

  1996cited by this paper
• The effects of continuous and intermittent delivery of antigens of Boophilus microplus on the development of murine antibodies.

  1995cited by this paper
• Induction of protective cytotoxic T cells with viral proteins

  1994cited by this paper
• The influence of antigen organization on B cell responsiveness.

  1993cited by this paper
• Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells.

  1993cited by this paper
• Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus

  1993cited by this paper
• Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.

  1992cited by this paper
• Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

  1992cited by this paper
• Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL.

  1991cited by this paper
• Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates.

  1991cited by this paper
• Differential stability of antigenic MHC class I-restricted synthetic peptides.

  1991cited by this paper
• Approaching the asymptote? Evolution and revolution in immunology.

  1989cited by this paper
• Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen

  1989cited by this paper
• Cellular mechanisms of immunologic tolerance.

  1983cited by this paper
• Immunological unresponsiveness.

  1973cited by this paper
• Induction of immunological paralysis in two zones of dosage

  1964cited by this paper

• Mesoporous Silica: A Promising Adjuvant for Cancer Vaccines.

  2026cites this paper
• Vaccination with an African Swine Fever Virus Multiepitope Protein Chitosan Nanoparticle-Based Subunit Vaccine Elicits Robust Immune Responses In Vivo.

  2026cites this paper
• Engineering gene expression dynamics via self-amplifying RNA with drug-responsive non-structural proteins

  2025cites this paper
• Development of a single-dose Q fever vaccine with an injectable nanoparticle-loaded hydrogel: effect of sustained co-delivery of antigen and adjuvant

  2025cites this paper
• Intranodal injection of neoantigen-bearing engineered Lactococcus lactis triggers epitope spreading and systemic tumor regressions

  2025cites this paper
• Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines

  2025cites this paper
• Dynamical Analysis of a Simple Tumor‐Immune Model With Two‐Stage Lymphocytes

  2025cites this paper
• Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability

  2025cites this paper
• Therapeutic Colorectal Cancer Vaccines: Emerging Modalities and Translational Opportunities

  2025cites this paper
• Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study

  2025cites this paper
• Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications

  2025cites this paper
• TLR7 Agonist-Loaded Gadolinium Oxide Nanotubes Promote Anti-Tumor Immunity by Activation of Innate and Adaptive Immune Responses

  2024cites this paper
• Intra‐lymph node crosslinking of antigen‐bearing polymers enhances humoral immunity and dendritic cell activation

  2024cites this paper
• Multilayered Immunity by Tissue-Resident Lymphocytes in Cancer.

  2024cites this paper
• Vaccine Strategies to Elicit Mucosal Immunity

  2024cites this paper
• Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines.

  2024cites this paper
• Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy

  2024cites this paper
• Adjuvanted Modified Bacterial Antigens for Single-Dose Vaccines

  2024cites this paper
• A dual-STING-activating nanosystem expands cancer immunotherapeutic temporal window

  2024cites this paper
• Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response

  2024cites this paper
• Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes

  2024cites this paper
• A long-term stable cold-chain-friendly HIV mRNA vaccine encoding multi-epitope viral protease cleavage site immunogens inducing immunogen-specific protective T cell immunity

  2024cites this paper
• Dictating the spatial-temporal delivery of molecular adjuvant and antigen for the enhanced vaccination.

  2024cites this paper
• Modulating Adjuvant Release Kinetics From Scaffold Vaccines to Tune Adaptive Immune Responses

  2024cites this paper
• Improved biodistribution and enhanced immune response of subunit vaccine using a nanostructure formed by self-assembly of ascorbyl palmitate.

  2024cites this paper
• Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy

  2024cites this paper
• Size Tuning of Mesoporous Silica Adjuvant for One-Shot Vaccination with Long-Term Anti-Tumor Effect

  2024cites this paper
• Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies

  2023cites this paper
• Therapeutic cancer vaccines: advancements, challenges and prospects

  2023cites this paper
• Two-dose “extended priming” immunization amplifies humoral immune responses by synchronizing vaccine delivery with the germinal center response

  2023cites this paper
• Exponentially decreasing exposure of antigen generates anti-inflammatory T-cell responses

  2023cites this paper
• Neoantigen-Based Nanovaccine In Combination with Immune Checkpoint Inhibitors Abolish Postsurgical Tumor Recurrence and Metastasis.

  2023cites this paper
• Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations

  2023cites this paper
• Reprogramming dendritic cells through the immunological synapse: A two‐way street

  2023cites this paper
• Short‐course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy

  2023cites this paper
• Complex Dynamics for an Immunosuppressive Infection Model with Virus Stimulation Delay and Nonlinear Immune Expansion

  2023cites this paper
• Nanocarrier vaccine therapeutics for global infectious and chronic diseases

  2023cites this paper
• Towards a quantitative theory of tolerance.

  2023cites this paper
• Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation

  2023cites this paper
• Maternal antibodies induced by a live attenuated vaccine protect neonatal mice from cytomegalovirus

  2023cites this paper
• Complex dynamic behaviors of a tumor-immune system with two delays in tumor actions

  2022cites this paper
• Dominant Antiviral CD8+ T Cell Responses Empower Prophylactic Antibody-Eliciting Vaccines Against Cytomegalovirus

  2022cites this paper
• Enhanced immune responses to vaccine antigens in the corneal stroma.

  2022cites this paper
• Biochemistry of Corona Virus: An Overveiw

  2022influential citation
• Dynamic Analysis of a Model on Tumor-Immune System with Regulation of PD-1/PD-L1 and Stimulation Delay of Tumor Antigen

  2022cites this paper
• Evaluation of two different vaccine platforms for immunization against melioidosis and glanders

  2022cites this paper
• Antigen transfer and its effect on vaccine-induced immune amplification and tolerance

  2022cites this paper
• Recent advancements in single dose slow-release devices for prophylactic vaccines.

  2022cites this paper
• Cancer vaccines: Building a bridge over troubled waters.

  2022cites this paper
• Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines

  2022cites this paper
• Dynamic Analysis of a Model on Tumor-Immune System with Regulation of PD-1/PD-L1 and Stimulation Delay of Tumor Antigen

  2022cites this paper
• Elastic Nanovaccine Enhances Dendritic Cell-Mediated Tumor Immunotherapy.

  2022cites this paper
• Sustained delivery approaches to improving adaptive immune responses.

  2022cites this paper
• Immunization with a bicistronic DNA vaccine modulates systemic IFN-γ and IL-10 expression against Vibrio cholerae infection.

  2022cites this paper
• Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans

  2022cites this paper
• Advanced materials for the delivery of vaccines for infectious diseases

  2022cites this paper
• Contributions of PD‐L1 reverse signaling to dendritic cell trafficking

  2021cites this paper
• Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines

  2021cites this paper
• PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance.

  2021cites this paper
• Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2

  2021cites this paper
• A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions

  2021cites this paper
• Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy.

  2021cites this paper
• Complex dynamics of a tumor-immune system with antigenicity

  2021cites this paper
• Dynamics of a chronic virus infection model with viral stimulation delay

  2021cites this paper
• Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles.

  2021cites this paper
• Demystifying particle-based oral vaccines

  2021cites this paper
• Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines

  2021cites this paper
• Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery.

  2020cites this paper
• Injectable hydrogels for sustained co-delivery of subunit vaccines enhance humoral immunity

  2020cites this paper
• Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines

  2020cites this paper
• Rapid assessment of T-cell receptor specificity of the immune repertoire

  2020cites this paper
• Single-shot Mesoporous Silica Rods Scaffold for Induction of Humoral Responses Against Small Antigens

  2020cites this paper
• High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence

  2020cites this paper
• Development of nano-carriers for Leishmania vaccine delivery

  2020cites this paper
• Diphtheria toxoid dissolving microneedle vaccination: adjuvant screening and effect of repeated-fractional dose administration.

  2020cites this paper
• Biomaterial Approaches for Understanding and Overcoming Immunological Barriers to Effective Oral Vaccinations

  2020cites this paper
• E ffi cient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets

  2020cites this paper
• Qualitative analysis of a simple tumor-immune system with time delay of tumor action

  2020cites this paper
• Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases

  2020cites this paper
• Stability Studies of Vaccines

  2020cites this paper
• Single‐Shot Mesoporous Silica Rods Scaffold for Induction of Humoral Responses Against Small Antigens

  2020cites this paper
• COVID-19: Mechanisms of Vaccination and Immunity

  2020cites this paper
• Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity

  2020cites this paper
• PD-L1 Reverse Signaling in Dermal Dendritic Cells Promotes Dendritic Cell Migration Required for Skin Immunity

  2020cites this paper
• Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities.

  2020cites this paper
• Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines

  2020cites this paper
• Self-Assembling Peptides for Vaccine Development and Antibody Production

  2020cites this paper
• Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets.

  2020cites this paper
• Controlling timing and location in vaccines

  2020cites this paper
• Sustained Co-evolution in a Stochastic Model of Cancer-Immune Interaction.

  2019cites this paper
• Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy

  2019cites this paper
• Expression kinetics and innate immune response after electroporation and lipid nanoparticle mediated delivery of a self-amplifying mRNA in the skin of mice

  2019cites this paper
• Extended delivery of vaccines to the skin improves immune responses

  2019cites this paper
• Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease

  2019cites this paper
• Implantable Microneedles with an Immune-Boosting Function for Effective Intradermal Influenza Vaccination.

  2019cites this paper
• At the bench: Engineering the next generation of cancer vaccines

  2019cites this paper
• Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the Skin

  2019cites this paper
• Particulate carrier systems as adjuvants for cancer vaccines.

  2019cites this paper
• Temporal release of a three-component protein subunit vaccine from polymer multilayers.

  2019cites this paper
• Murine CD8 T‐cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density

  2019cites this paper